| Literature DB >> 24341701 |
Jing Tao, Yi-tong Ma1, Yang Xiang, Xiang Xie, Yi-ning Yang, Xiao-mei Li, Zhen-Yan Fu, Xiang Ma, Fen Liu, Bang-dang Chen, Zi-xiang Yu, You Chen.
Abstract
BACKGROUND: Prevalence of cardiovascular disease (CVD) risk factors have been scarcely studied in Xinjiang, a multi-ethnic region.Entities:
Mesh:
Year: 2013 PMID: 24341701 PMCID: PMC3866600 DOI: 10.1186/1476-511X-12-185
Source DB: PubMed Journal: Lipids Health Dis ISSN: 1476-511X Impact factor: 3.876
Characteristics of all participants and by ethnic groups in Xinjiang
| | ||||
|---|---|---|---|---|
| Age (y) | 51.1±10.5 | 51.3±10.3 | 51.9±11.0 | 49.7±10.0 |
| Gender (female, %) | 6,337 (54.6) | 2,179 (58.6) | 2,493 (53.1) | 1,665 (52.1) |
| BMI (kg/m2)* | 25.9±4.2 | 25.1±3.5 | 26.0±4.4 | 26.8±4.8 |
| SBP (mmHg)& | 134.9±22.2 | 132.2±21.0 | 132.4±19.7 | 141.9±25.2 |
| DBP (mmHg)* | 85.2±16.8 | 81.0±14.7 | 85.4±15.5 | 89.8±19.6 |
| FBG (mmol/L)# | 5.15±1.69 | 5.32±1.80 | 4.94±1.65 | 5.16±1.55 |
| TG (mmol/L)$ | 1.27±0.82 | 1.39±0.84 | 1.39±0.78 | 1.01±0.37 |
| TC (mmol/L)* | 4.64±1.12 | 4.39±1.09 | 4.71±1.08 | 4.82±1.17 |
| HDL-C (mmol/L)& | 1.26±0.46 | 1.26±0.48 | 1.25±0.46 | 1.29±0.43 |
| LDL-C (mmol/L)** | 2.88±0.92 | 2.86±0.92 | 2.87±0.92 | 2.90±0.93 |
SBP systolic blood pressure, DBP diastolic blood pressure, BMI body mass index, TC serum total cholesterol, TG triglyceride, LDL-C low-density lipoprotein cholesterol, HDL-C high-density lipoprotein cholesterol, FBG fasting blood glucose.
The differences between ethnic groups were performed by F-test or by χ2test.
*Significantly higher for Kazakh and Uygur than Han, there were differences between the three groups. (All P < 0.001).
&Significantly higher for Kazakh than Uygur and Han (P < 0.05), but there was no difference between Uygur and Han.
#Significantly higher for Han than Uygur and Kazakh, there were differences between the three groups. (All P < 0.001).
$Levels were log-transformed to normalize their distribution, and significantly higher for Uygur and Han than Kazakh (P < 0.001), but there was no difference between Uygur and Han.
**No difference between the three groups (P > 0.05).
Age- and gender-standardized prevalence of CVD risk factors in Xinjiang by ethnic groups
| Total | | | | | |
| Overall(11608) | 44.2 | 5.5 | 15.6 | 51.7 | 28.6 |
| 35-44y(3999) | 28.1 | 3.1 | 12.7 | 48.0 | 30.6 |
| 45-54y(3339) | 43.8 | 3.2 | 17.3 | 52.9 | 29.7 |
| 55-64y(2559) | 56.2 | 6.6 | 18.6 | 54.4 | 26.1 |
| 65-74y(1711) | 65.0 | 8.4 | 14.7 | 53.5 | 25.6 |
| Men(5271) | 46.5 | 6.6 | 15.3 | 54.5 | 56.3 |
| Women(6337) | 42.3 | 4.6 | 15.9 | 49.3 | 5.6 |
| Han | | | | | |
| Overall(3717) | 36.0 | 7.1 | 8.1 | 53.3 | 19.3 |
| 35-44y(1158) | 19.1 | 3.8 | 5.8 | 49.3 | 18.1 |
| 45-54y(1109) | 37.5 | 8.4 | 6.5 | 53.1 | 20.1 |
| 55-64y(952) | 46.0 | 8.1 | 11.7 | 58.4 | 20.1 |
| 65-74y(498) | 52.6 | 10.4 | 10.4 | 53.6 | 19.1 |
| Men(1583) | 35.1 | 8.4 | 8.9 | 54.4 | 45.4 |
| Women(2179) | 36.6 | 6.0 | 7.3 | 52.6 | 1.0 |
| Uygur | | | | | |
| Overall(4695) | 43.7 | 5.4 | 17.6 | 54.3 | 31.1 |
| 35-44y(1643) | 29.2 | 2.8 | 16.2 | 51.6 | 32.9 |
| 45-54y(1228) | 37.7 | 5.5 | 20.0 | 57.1 | 35.2 |
| 55-64y(948) | 55.8 | 7.6 | 17.5 | 54.5 | 26.5 |
| 65-74y(876) | 66.1 | 7.2 | 15.3 | 55.1 | 26.9 |
| Men(2202) | 46.5 | 6.0 | 14.8 | 58.8 | 63.6 |
| Women(2493) | 41.2 | 5.0 | 19.6 | 50.3 | 2.4 |
| Kazakh | | | | | |
| Overall(3196) | 54.6 | 3.4 | 24.5 | 45.9 | 35.8 |
| 35-44y(1198) | 35.1 | 2.5 | 18.8 | 42.0 | 39.6 |
| 45-54y(1002) | 58.2 | 4.2 | 27.3 | 47.6 | 33.7 |
| 55-64y(659) | 71.3 | 3.2 | 30.2 | 48.6 | 34.1 |
| 65-74y(337) | 80.7 | 5.0 | 24.9 | 49.3 | 31.8 |
| Men(1531) | 58.1 | 4.8 | 25.1 | 48.3 | 56.6 |
| Women(1665) | 51.4 | 2.2 | 23.8 | 43.6 | 16.6 |
Hypertension was defined as SBP ≥ 140 mmHg and/or DBP ≥ 90 mmHg and/or current antihypertensive drug use. Diabetes was defined as fasting plasma glucose ≥ 6.99 mmol/L and/or current diabetes drug use. Obesity was defined as BMI ≥ 30 kg/m2. Dyslipidemia was defined as TG ≥ 2.26 mmol/L, TC ≥ 6.22 mmol/L, HDL-C < 1.04 mmol/L, LDL-C ≥ 4.14 mmol/L, and/or current lipid-lowering drug use.
Figure 1Age-standardized prevalence of adverse CVD risk profiles among Xinjiang participants stratified by gender groups (top), age groups (middle), and ethnic groups (bottom).
Adjusted* odds ratios (95% CI) of having one, two or three or more vs. none CVD risk factors according to gender, age, and ethnic groups
| Ethnic groups | | | |
| Han | 1.00 (ref) | 1.00 (ref) | 1.00 (ref) |
| Uygur | 1.16 (1.03-1.29) | 1.29 (1.14-1.46) | 1.55 (1.32-1.83) |
| Kazakh | 1.72 (1.50-1.97) | 2.75 (2.37-3.18) | 4.03 (3.37-4.82) |
| Age groups | | | |
| 35-44y | 1.00 (ref) | 1.00 (ref) | 1.00 (ref) |
| 45-54y | 1.30 (1.15-1.47) | 2.00 (1.75-2.29) | 2.26 (1.91-2.69) |
| 55-64y | 1.90 (1.65-2.19) | 3.50 (3.00-4.08) | 3.96 (3.28-4.79) |
| 65-74y | 2.23 (1.87-2.65) | 4.27 (3.56-5.13) | 4.82 (3.87-6.00) |
| Male gender | 1.96 (1.76-2.18) | 3.54 (3.15-3.97) | 6.55 (5.68-7.56) |
*All variables (age, gender and ethnic groups) were included in the same models; thus the odds ratios for age groups were adjusted for gender and ethnic group; the odds ratios for gender were adjusted for age groups and ethnic group; and the odds ratios for ethnic grouping were adjusted for age groups and gender.